Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,368.00
-81.50 (-1.50%)
Aug 14, 2026, 3:15 PM IST
Alkem Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 2,479 | 3,041 | 4,551 | 2,738 | 2,322 |
Short-Term Investments | - | 35,823 | 27,032 | 32,036 | 7,339 | 9,424 |
Trading Asset Securities | - | 2,313 | 7,706 | 1,436 | 1,355 | 1,385 |
Cash & Short-Term Investments | 40,615 | 40,615 | 37,779 | 38,023 | 11,432 | 13,130 |
Cash Growth | 7.51% | 7.51% | -0.64% | 232.62% | -12.94% | -25.13% |
Accounts Receivable | - | 30,049 | 25,076 | 22,855 | 21,442 | 18,880 |
Other Receivables | - | 1,140 | 782.1 | 1,658 | 1,782 | 1,607 |
Receivables | - | 31,255 | 25,949 | 24,603 | 23,292 | 20,689 |
Inventory | - | 33,332 | 29,224 | 26,612 | 26,075 | 30,055 |
Prepaid Expenses | - | 800.2 | 595.3 | 499.1 | 443.9 | 564.4 |
Restricted Cash | - | 3.6 | - | - | - | - |
Other Current Assets | - | 16,099 | 15,911 | 14,378 | 26,054 | 19,915 |
Total Current Assets | - | 122,105 | 109,458 | 104,116 | 87,297 | 84,354 |
Property, Plant & Equipment | - | 32,285 | 28,627 | 25,570 | 25,135 | 27,659 |
Long-Term Investments | - | 22,920 | 12,988 | 4,051 | 5,249 | 8,803 |
Goodwill | - | 5,236 | 4,231 | 4,167 | 4,132 | 4,031 |
Other Intangible Assets | - | 4,006 | 1,146 | 575.8 | 793.9 | 721.9 |
Long-Term Deferred Tax Assets | - | 18,194 | 17,383 | 15,148 | 13,025 | 13,093 |
Other Long-Term Assets | - | 3,983 | 3,078 | 2,120 | 1,855 | 1,950 |
Total Assets | - | 208,730 | 176,911 | 155,749 | 137,567 | 140,692 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 22,442 | 19,374 | 17,481 | 11,650 | 11,734 |
Accrued Expenses | - | 6,057 | 5,594 | 5,308 | 9,248 | 7,941 |
Short-Term Debt | - | 10,853 | 7,349 | 11,726 | 13,071 | 25,706 |
Current Portion of Long-Term Debt | - | 458 | 169.9 | 13.4 | 0.3 | 1.2 |
Current Portion of Leases | - | 468.8 | 506.9 | 151.8 | 192 | 216 |
Current Income Taxes Payable | - | 665.4 | 611 | 549.9 | 234.4 | 163.2 |
Current Unearned Revenue | - | 39 | 39 | 39.1 | 10.5 | 12.4 |
Other Current Liabilities | - | 6,845 | 6,027 | 4,676 | 2,665 | 2,280 |
Total Current Liabilities | - | 47,827 | 39,670 | 39,946 | 37,072 | 48,053 |
Long-Term Debt | - | 4,925 | 3,109 | 400 | - | 93.8 |
Long-Term Leases | - | 3,768 | 2,674 | 1,893 | 703.3 | 664.7 |
Long-Term Unearned Revenue | - | 180.8 | 219.5 | 258.4 | 88 | 79.2 |
Pension & Post-Retirement Benefits | - | 2,841 | 2,157 | 1,931 | 1,702 | 1,552 |
Long-Term Deferred Tax Liabilities | - | 151.2 | - | - | - | - |
Other Long-Term Liabilities | - | 5,549 | 4,746 | 4,178 | 3,652 | 1,775 |
Total Liabilities | - | 65,240 | 52,575 | 48,605 | 43,217 | 52,219 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 239.1 | 239.1 | 239.1 | 239.1 | 239.1 |
Retained Earnings | - | 136,508 | 119,603 | 102,970 | 90,392 | 85,811 |
Comprehensive Income & Other | - | 1,454 | 7 | -88 | -178.4 | 328.5 |
Total Common Equity | 138,201 | 138,201 | 119,849 | 103,121 | 90,453 | 86,379 |
Minority Interest | - | 5,288 | 4,488 | 4,023 | 3,897 | 2,094 |
Shareholders' Equity | 143,489 | 143,489 | 124,336 | 107,144 | 94,350 | 88,473 |
Total Liabilities & Equity | - | 208,730 | 176,911 | 155,749 | 137,567 | 140,692 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 20,472 | 20,472 | 13,809 | 14,184 | 13,967 | 26,682 |
Net Cash (Debt) | 20,143 | 20,143 | 23,970 | 23,839 | -2,535 | -13,552 |
Net Cash Growth | -15.97% | -15.97% | 0.55% | - | - | - |
Net Cash Per Share | 168.47 | 168.47 | 200.48 | 199.38 | -21.20 | -113.34 |
Filing Date Shares Outstanding | 119.56 | 119.57 | 119.57 | 119.57 | 119.57 | 119.57 |
Total Common Shares Outstanding | 119.56 | 119.57 | 119.57 | 119.57 | 119.57 | 119.57 |
Working Capital | - | 74,278 | 69,789 | 64,170 | 50,225 | 36,301 |
Book Value Per Share | 1155.87 | 1155.87 | 1002.37 | 862.46 | 756.52 | 722.44 |
Tangible Book Value | 128,958 | 128,958 | 114,472 | 98,377 | 85,527 | 81,626 |
Tangible Book Value Per Share | 1078.56 | 1078.56 | 957.40 | 822.79 | 715.32 | 682.69 |
Land | - | 1,252 | 1,245 | 1,365 | 1,369 | 1,373 |
Buildings | - | 10,029 | 9,676 | 10,226 | 8,786 | 9,672 |
Machinery | - | 29,471 | 24,848 | 23,690 | 21,710 | 22,554 |
Construction In Progress | - | 1,379 | 4,766 | 1,484 | 3,103 | 3,395 |
Leasehold Improvements | - | 3,576 | 250.1 | 107 | - | - |